USPTO serial 90668212
RELIEF, MULTIPLIED.
Reviewed by CopyMark Law Group
Status 807Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- LUEKEN, ABIGAIL JOSEPHINE
- Law office
- TMEG LAW OFFICE 109
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with RELIEF, MULTIPLIED.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Redwood City, CA, US
Redwood City, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mehul Jani
2560 General Armistead AvenueAudubon, PA 19403United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software application for use with a medical device for pain control to select, optimize, and adjust electrical stimulation therapy, based on input from the user; downloadable mobile applications for use with a medical device for pain control to select, optimize, and adjust electrical stimulation therapy; remote control for use with an electrical stimulation device for pain control; charger for use with an electrical stimulation device for pain control; remote control for a medical device for use in tissue and neural tissue for modulating neurological signals; charger for a medical device for use in tissue and neural tissue for modulating neurological signals; remote control for an electrical neuromodulation therapy device for pain control; charger for an electrical neuromodulation therapy device for pain control; remote controls for medical devices, namely, implantable electrical stimulation devices; chargers for medical devices, namely, implantable electrical stimulation devices; remote controls for medical devices, namely, electrical stimulation devices for pain control; chargers for medical devices, namely, electrical stimulation devices for pain control | ACTIVE | Mar 29, 2022 |
| 010 | Medical device, namely, an implantable electrical stimulation device for pain control; medical device, namely, an electrical spinal cord stimulator for pain control; medical and surgical instruments and apparatus, namely, devices for use in tissue and neural tissue for modulating neurological signals and components specially adapted for use therewith; medical electrodes, electrode arrays, remote controls, chargers, and other parts and accessories specially adapted for use with an electrical stimulation device for pain control sold as a unit; medical electrodes for use with an electrical stimulation device for pain control; electrode arrays for use with an electrical stimulation device for pain control; medical device for use in tissue and neural tissue for modulating neurological signals, and parts and accessories specially adapted for use therewith, namely, medical electrodes, remote controls, and chargers sold as a unit; medical electrodes for a medical device for use in tissue and neural tissue for modulating neurological signals; electrical neuromodulation therapy device for pain control, and parts and accessories specially adapted for use therewith, namely, medical electrodes, remote controls, and chargers sold as a unit; medical electrodes for an electrical neuromodulation therapy device for pain control; medical electrodes, electrode arrays, leads, surgical leads, paddles, paddle leads, remote controls, and chargers for medical devices, namely, implantable electrical stimulation devices and electrical stimulation devices for pain control sold as a unit; medical electrodes for use with implantable electrical stimulation devices; electrode arrays for use with implantable electrical stimulation devices; leads for use with implantable electrical stimulation devices; surgical leads for use with implantable electrical stimulation devices; paddles for use with implantable electrical stimulation devices; paddle leads for use with implantable electrical stimulation devices; leads for use with electrical stimulation devices for pain control; surgical leads for use with electrical stimulation devices for pain control; paddles for use with electrical stimulation devices for pain control; paddle leads for use with electrical stimulation devices for pain control; implantable pulse generator for use with an electrical stimulation medical device for pain control; implantable pulse generator for use with an electrical spinal cord stimulator for pain control; implantable pulse generator and embedded computer software to program, optimize, and adjust electrical stimulation therapy, for use with a medical device, namely, an electrical spinal cord stimulator for delivering pain therapy and for managing pain; pulse generator for use with an electrical stimulation medical device for pain control; pulse generator for use with an electrical spinal cord stimulator for pain control; pulse generator and embedded computer software to program, optimize, and adjust electrical stimulation therapy, for use with a medical device, namely, an electrical spinal cord stimulator for delivering pain therapy and for managing pain; feature of a medical device for pain management in the nature of recorded computer software sold as a component of an electrical stimulation device that enables remote optimization of electrical stimulation therapy; feature of a medical device for pain management in the nature of recorded computer software sold as a component of a spinal cord stimulator that enables remote optimization of electrical stimulation therapy; feature of a medical device for pain management in the nature of a programming unit sold as a component of an electrical stimulation device that enables remote optimization of electrical stimulation therapy; feature of a medical device for pain management in the nature of a programming unit sold as a component of a spinal cord stimulator that enables remote optimization of electrical stimulation therapy; medical electrical stimulation therapy device for pain management | ACTIVE | Mar 29, 2022 |
| 035 | Medical records claims coding assistance services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from private insurance and government healthcare payers; business administration of physician's assistance programs featuring insurance plan services that facilitate patient access to medical devices by providing physicians and other healthcare providers with insurance referrals; business administration of physician's assistance programs featuring insurance plan services that facilitate patient access to medical devices by providing physicians and other healthcare providers with insurance support services, namely, assistance and support services, namely, medical billing and records claims coding assistance services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from private insurance and government healthcare payers | ACTIVE | Mar 29, 2022 |
| 036 | Administration of physician's assistance programs featuring insurance plan services that facilitate patient access to medical devices by providing physicians and other healthcare providers with insurance reimbursement assistance and support services, namely, prior authorizations, prior authorization appeals, claim appeals, and coverage identification and guidance, and updating and reporting of insurance benefits to patients | ACTIVE | Mar 29, 2022 |
| 041 | Patient support program, namely, providing training on the use and optimization of a pain management device | ACTIVE | Mar 29, 2022 |
| 042 | Providing temporary use of online, non-downloadable software, namely, cloud-based patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; platform as a service (PAAS) featuring a cloud-based patient management and support software platform for receiving, storing, tracking, managing, and analyzing patient medical information; software as a service (SAAS) featuring cloud-based patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; providing temporary use of online, non-downloadable medical software for receiving, storing, tracking, managing, and analyzing patient medical information; providing online non-downloadable computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy, based on input from the user | ACTIVE | Mar 29, 2022 |
| 044 | Providing online information in the field of pain management; remote patient support program, namely, remotely provided patient therapy optimization services to facilitate use and optimization of a pain management device; patient support program, namely, providing information on the use and optimization of a pain management device; medical services, namely, electrical stimulation therapy for pain management | ACTIVE | Mar 29, 2022 |
| 045 | Administration of physician's assistance programs featuring insurance plan services that facilitate patient access to medical devices by providing physicians and other healthcare providers with insurance support services, namely, conducting insurance benefit investigations for healthcare providers and their patients | ACTIVE | Mar 29, 2022 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nevro Corp.
- Other trademarks owned by Nevro Corp.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named RELIEF, MULTIPLIED.
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Sep 15, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jun 15, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2026 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 14, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 12, 2026 | IUAF | USE AMENDMENT FILED | — |
| May 11, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jan 28, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 28, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 28, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 14, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 13, 2025 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 7, 2025 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 7, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 21, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 21, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 21, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 21, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 21, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 12, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 9, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 9, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 9, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 4, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 4, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 4, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 8, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 8, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 10, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 9, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 9, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 9, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 10, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 8, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 8, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 8, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 9, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 14, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 14, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 22, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 6, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 1, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 31, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 31, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 15, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 15, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 15, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 1, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 30, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 30, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 3, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 17, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 13, 2021 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Oct 13, 2021 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jul 30, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |